Blennow, O <br/><br/>
Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.  [electronic resource] 

 -  Bone marrow transplantation  Dec 2010 
 - 1710-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2010.38  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Amphotericin B--therapeutic use<br/>Antifungal Agents--therapeutic use<br/>Aspergillosis--drug therapy<br/>Aspergillus--genetics<br/>Candida--genetics<br/>Candidiasis--drug therapy<br/>Child<br/>Female<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Mycoses--drug therapy<br/>Polymerase Chain Reaction--methods<br/>Prospective Studies<br/>Risk Factors<br/>Treatment Outcome<br/>Young Adult